Involvement of platelet‐activating factor in zymosan‐induced rat pleurisy
- 1 December 1991
- Vol. 26 (12Part2) , 1408-1411
- https://doi.org/10.1007/bf02536577
Abstract
The role of platelet‐activating factor (PAF) in inflammatory reactions was studied in zymosan‐induced rat pleurisy. Pleurisy was induced by injection of a 2% zymosan suspension into the pleural cavity of rats. The time course of pleural exudate accumulation, the exudation rate, and exudate leukocyte numbers were followed then for 96 hr. Peak pleural exudate accumulation was about 3 mL at 24 hr, whereas the exudation rate increased biphasically with peaks at 0.5 hr and 5 hr. The migration of leukocytes into the pleural cavity increased with time up to 48 hr. The polymorphonuclear leukocytes were the dominant white cells in the exudate between 5 and 16 hr, but mononuclear leukocytes started to outnumber them around 24 hr. Pretreatment with cyproheptadine (5 mg/kg), an inhibitor of both histamine and seotonin, significantly suppressed pleural fluid accumulation and the exudation rate at 0.5 hr. The PAF antagonist CV‐6209 (1 mg/kg) significantly suppressed pleural fluid accumulation and the exudation rate at both 0.5 and 5 hr. At either time point, the parameters were not suppressed by indomethacin. We detected PAF activity in the high‐performance liquid chromatography (HPLC) fraction (with a retention time corresponding to that of authentic PAF) of the exudates at 0.5 hr, 5 hr, and 16 hr using an aggregation bioassay with washed rabbit platelets. The results suggest that in zymosan‐induced rat pleurisy, histamine and/or serotonin are the main mediators of exudation at 0.5 hr and that PAF may be partly responsible for exudation at 0.5 hr and later at 5 hr to 16 hr.Keywords
This publication has 18 references indexed in Scilit:
- Experimental approach to a role of the increased T-kininogen level in carrageenin-induced pleurisy of rats.The Japanese Journal of Pharmacology, 1989
- The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulationEuropean Journal of Pharmacology, 1988
- Detection of platelet-activating factor in exudates of rats with phorbol myristate acetate-induced pleurisyThrombosis Research, 1987
- Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of ratsEuropean Journal of Pharmacology, 1986
- Involvement of Arachidonic Acid Metabolites in Acute Inflammation: Detection of 6-Keto-PGF1α, Thromboxane B2 and PGD2 in Rat Pleurisy Induced by Phorbol Myristate AcetateThe Japanese Journal of Pharmacology, 1985
- Involvement of Histamine in Vascular Permeability Increase of the Rat Pleurisy Induced by Phorbol Myristate AcetateThe Japanese Journal of Pharmacology, 1984
- Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxiaBiochemical and Biophysical Research Communications, 1984
- Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytesEuropean Journal of Immunology, 1979
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959
- The Properdin System and Immunity: I. Demonstration and Isolation of a New Serum Protein, Properdin, and Its Role in Immune PhenomenaScience, 1954